$EEIQ
EpicQuest Education Group International Ltd Stock $eeiq

$eeiq Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 20-F Financial Statement

#000121390024008467 Filed on January 31, 2024

Income Statement

Concept	2023 Q3	2023	2022 Q3
Revenue	$2.292M	$5.712M	$2.275M
YoY Change	0.73%	-9.76%	1.56%
Cost Of Revenue	$732.6K	$1.502M	$693.8K
YoY Change	5.61%	-25.67%	6.05%
Gross Profit	$1.559M	$4.210M	$1.581M
YoY Change	-1.41%	-2.3%	-0.29%
Gross Profit Margin	68.03%	73.7%	69.51%
Selling, General & Admin	$5.492M	$8.761M	$5.417M
YoY Change	1.38%	-23.65%	103.17%
% of Gross Profit	352.23%	208.09%	342.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$247.0K	$407.0K	$140.5K
YoY Change	75.81%	61.45%	70.45%
% of Gross Profit	15.84%	9.67%	8.88%
Operating Expenses	$5.492M	$8.761M	$5.417M
YoY Change	1.38%	-23.65%	103.17%
Operating Profit	-$3.933M	-$7.123M	-$3.836M
YoY Change	2.52%	-0.59%	255.06%
Interest Expense	$32.26K	$53.09K	$22.26K
YoY Change	44.92%	100.64%	-179.84%
% of Operating Profit
Other Income/Expense, Net	$184.5K	$186.1K	$21.72K
YoY Change	749.36%	-77.28%	-69.68%
Pretax Income	-$3.716M	-$6.884M	-$3.792M
YoY Change	-2.0%	8.93%	265.81%
Income Tax	$453.9K	$289.5K	-$97.10K
% Of Pretax Income
Net Earnings	-$4.170M	-$6.763M	-$3.695M
YoY Change	12.86%	11.39%	366.26%
Net Earnings / Revenue	-181.95%	-118.38%	-162.39%
Basic Earnings Per Share		-$0.58
Diluted Earnings Per Share	-$0.35	-$0.58	-$0.33
COMMON SHARES
Basic Shares Outstanding	12.00M shares	11.66M shares
Diluted Shares Outstanding		11.66M shares

Balance Sheet

Concept	2023 Q3	2023	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.967M	$4.967M	$11.44M
YoY Change	-56.6%	-56.6%	-30.8%
Cash & Equivalents	$4.967M	$4.967M	$11.44M
Short-Term Investments
Other Short-Term Assets	$19.21M	$2.665M	$946.3K
YoY Change	1929.92%	181.61%	-39.37%
Inventory	$41.19K	$41.19K
Prepaid Expenses	$2.326M		$946.3K
Receivables	$36.50K	$143.7K	$47.64K
Other Receivables	$107.2K	$894.7K	$1.632M
Total Short-Term Assets	$8.711M	$8.711M	$14.07M
YoY Change	-38.08%	-38.08%	-28.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.041M	$3.159M	$2.205M
YoY Change	-7.43%	-0.71%	-46.3%
Goodwill	$2.653M		$854.9K
YoY Change	210.31%
Intangibles	$4.686M		$398.8K
YoY Change	1075.1%
Long-Term Investments			$5.086M
YoY Change
Other Assets	$0.00	$0.00	$411.9K
YoY Change	-100.0%	-100.0%	28.3%
Total Long-Term Assets	$10.50M	$10.50M	$9.934M
YoY Change	5.68%	5.68%	124.36%
TOTAL ASSETS
Total Short-Term Assets	$8.711M	$8.711M	$14.07M
Total Long-Term Assets	$10.50M	$10.50M	$9.934M
Total Assets	$19.21M	$19.21M	$24.00M
YoY Change	-19.97%	-19.97%	-0.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$210.1K	$210.1K	$2.121M
YoY Change	-90.09%	130.68%	-28.38%
Accrued Expenses	$559.4K	$829.0K	$461.2K
YoY Change	21.3%	33.47%	77.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.880M	$6.880M	$6.054M
YoY Change	13.64%	13.64%	-29.7%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$571.1K	$571.1K	$561.9K
YoY Change	1.64%	1.64%	21.62%
Total Long-Term Liabilities	$571.1K	$571.1K	$561.9K
YoY Change	1.64%	1.64%	21.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.880M	$6.880M	$6.054M
Total Long-Term Liabilities	$571.1K	$571.1K	$561.9K
Total Liabilities	$8.275M	$10.07M	$6.724M
YoY Change	23.08%	13.05%	-25.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.072M		-$2.417M
YoY Change	275.37%		-166.13%
Common Stock	$18.25M		$18.02K
YoY Change	101200.48%		9.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.143M	$9.143M	$15.10M
YoY Change
Total Liabilities & Shareholders Equity	$19.21M	$19.21M	$24.00M
YoY Change	-19.97%	-19.97%	-0.03%

Cashflow Statement

Concept	2023 Q3	2023	2022 Q3
OPERATING ACTIVITIES
Net Income	-$4.170M	-$6.763M	-$3.695M
YoY Change	12.86%	11.39%	366.26%
Depreciation, Depletion And Amortization	$247.0K	$407.0K	$140.5K
YoY Change	75.81%	61.45%	70.45%
Cash From Operating Activities	-$912.5K	-$5.253M	-$1.458M
YoY Change	-37.43%	13.85%	-145.64%
INVESTING ACTIVITIES
Capital Expenditures	$4.230K	$14.23K	$21.26K
YoY Change	-80.1%	-72.32%	-105.31%
Acquisitions		-$574.1K
YoY Change		-129.5%
Other Investing Activities	-$1.423M	-$863.4K	-$450.6K
YoY Change	215.9%	43.88%	-11364.75%
Cash From Investing Activities	-$1.438M	-$877.6K	-$471.8K
YoY Change	204.68%	34.71%	18.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.450M		469.9K
YoY Change	208.58%		-89.3%
NET CHANGE
Cash From Operating Activities	-912.5K	-$5.253M	-1.458M
Cash From Investing Activities	-1.438M	-$877.6K	-471.8K
Cash From Financing Activities	1.450M		469.9K
Net Change In Cash	-900.2K	-$6.138M	-1.460M
YoY Change	-38.36%	20.48%	-120.31%
FREE CASH FLOW
Cash From Operating Activities	-$912.5K	-$5.253M	-$1.458M
Capital Expenditures	$4.230K	$14.23K	$21.26K
Free Cash Flow	-$916.8K	-$5.267M	-$1.480M
YoY Change	-38.04%	12.9%	-141.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40280
CY2023	dei	Entity Registrant Name EntityRegistrantName	EpicQuest Education Group International Limited
CY2023	dei	Entity Address Country EntityAddressCountry	VG
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1209 N. University Blvd
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Middletown
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45042
CY2023	dei	Security12b Title Security12bTitle	Common Shares, $0.0016 par value per share
CY2023	dei	Trading Symbol TradingSymbol	EEIQ
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11998173	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	6413
CY2023	dei	Auditor Name AuditorName	ZH CPA, LLC
CY2023	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4966839	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11443059	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	338712	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36503	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	107179	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	47639	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2326185	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	946299	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	41185	usd
CY2022Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	485000	usd
CY2023Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	894743	usd
CY2022Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1147213	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8711346	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	14069210	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2041242	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2205084	usd
CY2022Q3	us-gaap	Long Term Investments LongTermInvestments	5086413	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	411934	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4686228	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398794	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1117554	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	976404	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2652766	usd
CY2022Q3	us-gaap	Goodwill Goodwill	854887	usd
CY2023Q3	us-gaap	Assets Assets	19209136	usd
CY2022Q3	us-gaap	Assets Assets	24002726	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2121051	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2120660	usd
CY2022Q3	us-gaap	Deposits Deposits	46040	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	1872	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	559375	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	461161	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4057517	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3286350	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6879815	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6054211	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	571131	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	561897	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	824480	usd
CY2023Q3	us-gaap	Liabilities Liabilities	8275426	usd
CY2022Q3	us-gaap	Liabilities Liabilities	6616108	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1250000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0015873
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0015873
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	31500000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	31500000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11998173	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11998173	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11350704	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11350704	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	19045	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	17697	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18232263	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-191029	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-307168	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7173125	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6128442	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1084313	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-410421	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16276866	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9071818	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2309114	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36284	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28939	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9143206	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13956510	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	1790504	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	2180108	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19209136	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24002726	usd
CY2023	us-gaap	Revenues Revenues	5712480	usd
CY2022	us-gaap	Revenues Revenues	6330428	usd
CY2021	us-gaap	Revenues Revenues	5341850	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1502255	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2021058	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1934237	usd
CY2023	us-gaap	Gross Profit GrossProfit	4210225	usd
CY2022	us-gaap	Gross Profit GrossProfit	4309370	usd
CY2021	us-gaap	Gross Profit GrossProfit	3407613	usd
CY2023	us-gaap	Selling Expense SellingExpense	1018894	usd
CY2022	us-gaap	Selling Expense SellingExpense	952888	usd
CY2021	us-gaap	Selling Expense SellingExpense	1732758	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10314223	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10521551	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3148256	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11333117	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11474439	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4881014	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7122892	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7165069	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1473401	usd
CY2023	us-gaap	Other Income OtherIncome	186137	usd
CY2022	us-gaap	Other Income OtherIncome	819135	usd
CY2021	us-gaap	Other Income OtherIncome	71640	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	53089	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	26463	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	9537	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	743	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	239231	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	845598	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	81920	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6883661	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6319471	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1391481	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11590	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16459	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13889	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	277874	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-207488	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-321057	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	289464	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-164887	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6762704	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5963555	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1084313	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	7345	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	28939	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7180470	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6157381	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1084313	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11655642	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11010240	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9160447	shares
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7482627	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1084313	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8537634	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14935948	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6128442	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2345002	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3455680	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1357369	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-28939	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16136618	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7173125	usd
CY2023	eeiq	Stock Issued During Period Value Share Buyback StockIssuedDuringPeriodValueShareBuyback	-7	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1899442	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	265631	usd
CY2023	eeiq	Stock Issued During Period Value Acquisition Of Additional Interest In Subsidiary StockIssuedDuringPeriodValueAcquisitionOfAdditionalInterestInSubsidiary	-187504	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7345	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10933710	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7173125	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-6128442	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1084313	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	407013	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	252097	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	126234	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2165073	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4813049	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	14038	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	25643	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-94698	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	277874	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-207488	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-321057	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	813064	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	4000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-217407	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-118608	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5176	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1323593	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-614548	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-71800	usd
CY2022Q3	eeiq	Yearended Spot Rate YearendedSpotRate	US$1=C$ 1.3752
CY2023	eeiq	Average Rate AverageRate	US$1=C$ 1.3486
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	45022	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	21170	usd
CY2021	eeiq	Increase Decrease Longterm Prepaid Expenses IncreaseDecreaseLongtermPrepaidExpenses	-159382	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-212817	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1320563	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1117184	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	233493	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1283314	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	961426	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-254342	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2293	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	480866	usd
CY2023	eeiq	Increase Decrease In Student Deposits IncreaseDecreaseInStudentDeposits	-46040	usd
CY2022	eeiq	Increase Decrease In Student Deposits IncreaseDecreaseInStudentDeposits	-635778	usd
CY2021	eeiq	Increase Decrease In Student Deposits IncreaseDecreaseInStudentDeposits	-313122	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5252527	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4613697	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	322190	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14231	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51410	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	618529	usd
CY2022	eeiq	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	305000	usd
CY2021	eeiq	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	-100000	usd
CY2022	eeiq	Repayment To Related Parties RepaymentToRelatedParties	270000	usd
CY2023	eeiq	Share Buyback ShareBuyback	1250007	usd
CY2023	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	187505	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-574108	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1945931	usd
CY2022	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	1920861	usd
CY2021	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	4000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-877635	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-651480	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-514529	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9321523	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	200000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9321523	usd
CY2023	eeiq	Effect Of Exchange Rate Changes On Cash And Cash Equivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents	-7346	usd
CY2022	eeiq	Effect Of Exchange Rate Changes On Cash And Cash Equivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents	-28938	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6137508	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5094115	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9129184	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11443059	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16537174	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7407990	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5305551	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11443059	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16537174	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10575	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14166	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	490250	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	561247	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	574483	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	572564	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	574483	usd
CY2022	eeiq	Average Rate AverageRate	US$1=C$ 1.2842*
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Actual amounts could differ from those estimates and differences could be material. Changes in estimates are recorded in the period they are identified.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Significant items subject to estimates include, purchase price allocation associated with business combinations, the recoverable amounts of goodwill and indefinite-lived intangible assets, the useful lives of long-lived assets and finite-lived intangible assets and deferred income taxes.</p>
CY2023Q3	eeiq	Yearended Spot Rate YearendedSpotRate	US$1=C$ 1.3535
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Certain risks and concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company’s financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable and notes receivable. As of September 30, 2023 and 2022, substantially all of the Company’s cash and cash equivalents were held in major financial institutions located in the US and Canada.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have significant trades receivable related to students as they are required to prepay service fees.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Therefore, there was no significant concentration risk for the Company as at September 30, 2023 and 2022.</p>
CY2023Q3	eeiq	Restricted Cash Percentage RestrictedCashPercentage	0.25	pure
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	14308	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.50	pure
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Restatement</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended September 30, 2023, the Company identified two adjustments related to its previously September 30, 2022 consolidated financial statements filed on January 19, 2023. These two adjustments are: i) a balance sheet reclassification error. The error was due to the 201,613 common shares issued for the acquisition of Ameri-Can (refer to Note 3 below) were redeemable at the option of the seller. The Company incorrectly classified these redeemable shares as equity instead of as financial liability; ii) an error related to an overstatement of its deferred income tax liabilities due to the Company did not offset its net-operating loss (“NOL”) with the deferred income tax liabilities for the same legal entity before providing full valuation allowance for the NOL. The Company has corrected the two errors in the year ended September 30, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The relevant notes, Notes 11, 12,13 and 16, to the consolidated financial statements have been restated to reflect the adjustments disclosed in the restatement. The following table summarizes the effect of the restatement on each financial statement line item as of the date, and for the period, indicated:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consolidated Balance Sheets</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended September 30,<br/> 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended September 30,<br/> 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As<br/> previously<br/> reported<br/> (US$)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Adjustment 1 (US$)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Adjustment 2 (US$)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As restated<br/> (US$)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 52%; text-align: left">Deferred income tax liabilities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">107,674</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(107,674</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Common shares subject to redemption</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,017</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(320</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,697</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Additional paid-in-capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,526,546</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,249,680</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,276,866</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 0.125in">Deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,416,788</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">107,674</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,309,114</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total shareholder’ equity</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,098,836</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,250,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">107,674</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13,956,510</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consolidated Statements of Operations and Comprehensive Loss</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended September 30,<br/> 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended September 30,<br/> 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As<br/> previously<br/> reported<br/> (US$)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Adjustment 2<br/> (US$)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">As restated<br/> (US$)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 64%; text-align: left">Deferred income tax recovery</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(99,814</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(107,674</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(207,488</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total income tax recovery</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(83,355</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(107,674</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(191,029</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,236,116</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,674</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,128,442</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Net loss attributable to common stockholders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,071,229</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,674</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,963,555</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,265,055</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,674</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,157,381</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><div style="-sec-ix-hidden: hidden-fact-122; -sec-ix-hidden: hidden-fact-121; -sec-ix-hidden: hidden-fact-120">Loss per share (basic and diluted)</div></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(0.55</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">0.01</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(0.54</td><td style="font-weight: bold; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Consolidated Statements of Cash flows</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><b> </b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Year Ended September 30,<br/> 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="text-align: center"><b>Year Ended September 30,<br/> 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">As<br/> previously</p> <p style="margin-top: 0; margin-bottom: 0">reported<br/> (US$)</p></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Adjustment 2<br/> (US$)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As restated</b></p> <p style="text-align: center; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><b>(US$)</b></p> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0in; width: 64%; text-align: left">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(6,236,116</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">107,674</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(6,128,442</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0in; text-align: left">Adjustments for items not affecting cash:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0in; text-align: left">Deferred income tax recovery</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(99,814</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(107,674</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(207,488</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Adjustment 1 does not have impacts to the consolidated statements of operations and comprehensive loss, loss per share and the consolidated statements of cash flows for the years ended September 30, 2023 and 2022.</p>
CY2023	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	201613	shares
CY2023	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	3000000	cad
CY2023Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	3000000	cad
CY2023Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	187505	usd
CY2023Q1	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	250000	cad
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	200000	cad
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	100000	cad
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	208321	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	20817	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1766100	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1800362	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	606686	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	691863	usd
CY2023Q3	eeiq	Prepaid Tuition Fees To Miami University PrepaidTuitionFeesToMiamiUniversity	258248	usd
CY2023Q3	eeiq	Prepaid Fees To Renda For Beijing Office Expenses PrepaidFeesToRendaForBeijingOfficeExpenses	1073429	usd
CY2022Q3	eeiq	Prepaid Fees To Renda For Beijing Office Expenses PrepaidFeesToRendaForBeijingOfficeExpenses	769717	usd
CY2023Q3	eeiq	Prepaid Fees To Dongbei University Of Finance And Economics PrepaidFeesToDongbeiUniversityOfFinanceAndEconomics	621420	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	106067	usd
CY2022Q3	us-gaap	Prepaid Insurance PrepaidInsurance	70517	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	104713	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	162308	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	106065	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2326185	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	946299	usd
CY2023	us-gaap	Depreciation Depreciation	214820	usd
CY2022	us-gaap	Depreciation Depreciation	220767	usd
CY2022	us-gaap	Defined Benefit Plan Other Costs DefinedBenefitPlanOtherCosts	1287795	usd
CY2023Q3	us-gaap	Disposal Group Deferred Gain On Disposal DisposalGroupDeferredGainOnDisposal	813064	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	4911521	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	431894	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	225293	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33100	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4686228	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398794	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	192193	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	33100	usd
CY2022	eeiq	Acquisition Of Ameri Can AcquisitionOfAmeriCan	4828123	usd
CY2022	eeiq	Additional Investment AdditionalInvestment	258290	usd
CY2022Q3	us-gaap	Long Term Investments LongTermInvestments	5086413	usd
CY2023	eeiq	Interest Accrued InterestAccrued	32116	usd
CY2023	eeiq	Additional Investment AdditionalInvestment	485000	usd
CY2023	eeiq	Exercise Of Conversion Feature ExerciseOfConversionFeature	5603529	usd
CY2022Q3	eeiq	Deferred Tax Rightofuse Assets DeferredTaxRightofuseAssets	237716	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1264691	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	345390	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	210100	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	91083	usd
CY2023Q3	eeiq	Student Refundable Deposits StudentRefundableDeposits	1407121	usd
CY2022Q3	eeiq	Student Refundable Deposits StudentRefundableDeposits	1614219	usd
CY2023Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	269621	usd
CY2022Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	159945	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	234209	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	255413	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2121051	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2120660	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3286350	usd
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4569664	usd
CY2023	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	4530733	usd
CY2022	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	3219950	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3759566	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	4503264	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4057517	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3286350	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.27	pure
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1558900	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	309593	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2383380	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	309593	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	824480	usd
CY2023Q3	us-gaap	Investment Owned Unrecognized Unrealized Appreciation Depreciation Net InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet	1886974	usd
CY2023	us-gaap	Investment Company Amount Received To Nav Excess Less InvestmentCompanyAmountReceivedToNavExcessLess	675153	usd
CY2023	us-gaap	Unrecorded Unconditional Purchase Obligation Term UnrecordedUnconditionalPurchaseObligationTerm	P20Y
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	2474843	shares
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	8737634	usd
CY2021Q3	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	200000	usd
CY2022Q3	us-gaap	Accounts Receivable Unapproved Contract Claims Amount Expected To Be Collected After One Year AccountsReceivableUnapprovedContractClaimsAmountExpectedToBeCollectedAfterOneYear	200000	usd
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	736247	shares
CY2022	eeiq	Aggregate Value AggregateValue	3455680	usd
CY2021Q4	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	1250000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	201614	shares
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11590	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16459	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13889	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	277874	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-207488	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-321057	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	289464	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-191029	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-307168	usd
CY2023	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-6883661	usd
CY2022	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-6319471	usd
CY2021	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-1391481	usd
CY2023	eeiq	Rate Differences In Various Jurisdictions RateDifferencesInVariousJurisdictions	-11590	usd
CY2022	eeiq	Rate Differences In Various Jurisdictions RateDifferencesInVariousJurisdictions	-16459	usd
CY2021	eeiq	Rate Differences In Various Jurisdictions RateDifferencesInVariousJurisdictions	-13889	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-277874	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	207488	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	321057	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	289464	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-191029	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-307168	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2562127	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	408481	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	261464	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	246502	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2823591	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	654983	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1005360	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	107674	usd
CY2023Q3	eeiq	Deferred Tax Rightofuse Assets DeferredTaxRightofuseAssets	259331	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1250000	usd
CY2023	eeiq	Redeemable Common Shares RedeemableCommonShares	201614	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	699083	shares
CY2023	eeiq	Aggregate Value AggregateValue	1654942	usd
CY2023	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	150000	shares
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	244500	usd
CY2023	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	201614	shares
CY2023	eeiq	Cash Paid CashPaid	1250000	usd
CY2023	eeiq	Aggregate Shares AggregateShares	90000	shares
CY2022	eeiq	Aggregate Shares AggregateShares	365000	shares
CY2023	eeiq	Total Stock Options Percentage TotalStockOptionsPercentage	0.25	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	2.21
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	4.1
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	2.21
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0399	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.012	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.742	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.279	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.06
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	365000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.1
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	365000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.21
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	455000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.73
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	365000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.06
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	273750	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.06
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	91250	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	90000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.11
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	158750	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.3
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	22500	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.11
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	47411	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y3M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	875000	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other Description ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOtherDescription	These share-based awards have a vesting period of ranging from 1 year to 2 years from the grant date in ranging from 3 equal instalments to 5 equal instalments in the vesting periods. During the year ended September 30, 2022, an aggregate of 640,000 shares were issued to these directors, officers and employees under the November 1, 2021 Grant.
CY2022	us-gaap	Restricted Stock Award Forfeitures Dividends RestrictedStockAwardForfeituresDividends	30000	usd
CY2021Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	27000	usd
CY2022Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	22500	usd
CY2022Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	22500	usd
CY2021Q4	eeiq	Annual Bonus Shares AnnualBonusShares	80000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.1
CY2022	eeiq	Annual Bonus Shares AnnualBonusShares	80000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3455680	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	90000	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	185000	shares
CY2023	us-gaap	Stock Dividends Shares StockDividendsShares	71519	shares
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	34421	usd
CY2023	eeiq	Share Based Awards Granted Fair Value ShareBasedAwardsGrantedFairValue	300000	shares
CY2023	eeiq	Fair Value Price FairValuePrice	1.63
CY2023	eeiq	Percentage Of Consulting Services PercentageOfConsultingServices	0.50	pure
CY2023	eeiq	Consulting Shares Issued ConsultingSharesIssued	150000	shares
CY2023Q1	eeiq	Sharebased Awards Granted Value SharebasedAwardsGrantedValue	3846	usd
CY2023Q1	eeiq	Sharebased Awards Granted Value SharebasedAwardsGrantedValue	27000	cny
CY2023	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	2564	shares
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1899442	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2165073	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4813049	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6762704	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5963555	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1084313	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11655642	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11010240	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9160447	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	642604	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	373941	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	247537	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1264082	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	133576	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1130506	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	559375	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	571131	usd
CY2022Q3	us-gaap	Loss Contingency Settlement Agreement Counterpartys Name LossContingencySettlementAgreementCounterpartysName	$40,000
CY2022	us-gaap	Lease Cost LeaseCost	40000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023	us-gaap	Revenues Revenues	5712480	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1502255	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8761031	usd
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	4550806	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	407013	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2165073	usd
CY2023	us-gaap	Other Income OtherIncome	186137	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	53089	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	6883661	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	289464	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-7173125	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	19209136	usd
CY2023Q3	us-gaap	Goodwill Goodwill	2652766	usd
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q3	us-gaap	Inventory Net InventoryNet		usd
CY2023Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments		usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2023Q3	us-gaap	Deposits Deposits		usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11010240	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11655642	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9160447	shares
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023	eeiq	Increase Decrease Longterm Prepaid Expenses IncreaseDecreaseLongtermPrepaidExpenses		usd
CY2022	eeiq	Increase Decrease Longterm Prepaid Expenses IncreaseDecreaseLongtermPrepaidExpenses		usd
CY2023	eeiq	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
CY2023	eeiq	Repayment To Related Parties RepaymentToRelatedParties		usd
CY2021	eeiq	Repayment To Related Parties RepaymentToRelatedParties		usd
CY2022	eeiq	Share Buyback ShareBuyback		usd
CY2021	eeiq	Share Buyback ShareBuyback		usd
CY2022	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries		usd
CY2021	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries		usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021	eeiq	Effect Of Exchange Rate Changes On Cash And Cash Equivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2022Q3	eeiq	Prepaid Tuition Fees To Miami University PrepaidTuitionFeesToMiamiUniversity		usd
CY2022Q3	eeiq	Prepaid Fees To Dongbei University Of Finance And Economics PrepaidFeesToDongbeiUniversityOfFinanceAndEconomics		usd
CY2022Q3	us-gaap	Security Deposit SecurityDeposit		usd
CY2021Q3	us-gaap	Long Term Investments LongTermInvestments		usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential		pure
CY2023	eeiq	Income Tax Calculated At Statutory Rate IncomeTaxCalculatedAtStatutoryRate		usd
CY2022	eeiq	Income Tax Calculated At Statutory Rate IncomeTaxCalculatedAtStatutoryRate		usd
CY2021	eeiq	Income Tax Calculated At Statutory Rate IncomeTaxCalculatedAtStatutoryRate		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2021	eeiq	Aggregate Shares AggregateShares		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested		usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11010240	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11655642	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9160447	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001781397

Files In Submission

Name	View Source	Status
0001213900-24-008467-index-headers.html	Edgar Link	pending
0001213900-24-008467-index.html	Edgar Link	pending
0001213900-24-008467.txt	Edgar Link	pending
0001213900-24-008467-xbrl.zip	Edgar Link	pending
eeiq-20230930.xsd	Edgar Link	pending
f20f2023ex12-1_epicquest.htm	Edgar Link	pending
f20f2023ex12-2_epicquest.htm	Edgar Link	pending
f20f2023ex13-1_epicquest.htm	Edgar Link	pending
f20f2023ex15-1_epicquest.htm	Edgar Link	pending
f20f2023ex4-15_epicquest.htm	Edgar Link	pending
f20f2023ex8-1_epicquest.htm	Edgar Link	pending
f20f2023_epicquest.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
eeiq-20230930_cal.xml	Edgar Link	unprocessable
eeiq-20230930_def.xml	Edgar Link	unprocessable
eeiq-20230930_lab.xml	Edgar Link	unprocessable
eeiq-20230930_pre.xml	Edgar Link	unprocessable
f20f2023_epicquest_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EEIQ
EpicQuest Education Group International Ltd Stock $eeiq

2023 Q3 Form 20-F Financial Statement

#000121390024008467 Filed on January 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EEIQ EpicQuest Education Group International Ltd Stock $eeiq

2023 Q3 Form 20-F Financial Statement

#000121390024008467 Filed on January 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EEIQ
EpicQuest Education Group International Ltd Stock $eeiq